Phagocytosis checkpoints as new targets for cancer immunotherapy

M Feng, W Jiang, BYS Kim, CC Zhang, YX Fu… - Nature Reviews …, 2019 - nature.com
Cancer immunotherapies targeting adaptive immune checkpoints have substantially
improved patient outcomes across multiple metastatic and treatment-refractory cancer types …

Current challenges and opportunities of photodynamic therapy against cancer

RV Huis in 't Veld, J Heuts, S Ma, LJ Cruz… - Pharmaceutics, 2023 - mdpi.com
BACKGROUND: Photodynamic therapy (PDT) is an established, minimally invasive
treatment for specific types of cancer. During PDT, reactive oxygen species (ROS) are …

Engineered nanomaterials for synergistic photo-immunotherapy

R Guo, S Wang, L Zhao, Q Zong, T Li, G Ling, P Zhang - Biomaterials, 2022 - Elsevier
Nanomaterial-synergized photodynamic therapy (PDT) and photothermal therapy (PTT), as
efficient and non-invasive treatment modalities, have shown significant advantages in …

Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death

S Marchi, S Patergnani, S Missiroli, G Morciano… - Cell calcium, 2018 - Elsevier
The endoplasmic reticulum (ER) and mitochondria cannot be considered as static structures,
as they intimately communicate, forming very dynamic platforms termed mitochondria …

CD47 blockade triggers T cell–mediated destruction of immunogenic tumors

X Liu, Y Pu, K Cron, L Deng, J Kline, WA Frazier… - Nature medicine, 2015 - nature.com
Macrophage phagocytosis of tumor cells mediated by CD47-specific blocking antibodies
has been proposed to be the major effector mechanism in xenograft models. Here, using …

Metal drugs and the anticancer immune response

B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …

Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo–immunotherapy

M Jiang, J Zeng, L Zhao, M Zhang, J Ma, X Guan… - Nanoscale, 2021 - pubs.rsc.org
Chemotherapy has been a conventional paradigm for cancer treatment, and multifarious
chemotherapeutic drugs have been widely employed for decades with significant …

Nanomedicine‐boosting tumor immunogenicity for enhanced immunotherapy

J Huang, B Yang, Y Peng, J Huang… - Advanced Functional …, 2021 - Wiley Online Library
Immunotherapy has revolutionized oncology remarkably and gained great improvements in
cancer therapy. However, tumor immunotherapy still encounters serious challenges …

Innate immune recognition of cancer

SR Woo, L Corrales, TF Gajewski - Annual review of …, 2015 - annualreviews.org
The observation that a subset of cancer patients show evidence for spontaneous CD8+ T
cell priming against tumor-associated antigens has generated renewed interest in the innate …

Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy

WD Yu, G Sun, J Li, J Xu, X Wang - Cancer letters, 2019 - Elsevier
Immunotherapies based on T cells have gained significant success in the treatment of
diverse cancers, however, several limitations also exist, including low response, acquired …